Anorexia of ageing: a key component in the pathogenesis of both sarcopenia and cachexia

The anorexia of aging was first recognized as a physiological syndrome 30 years ago. Its major causes are an alteration in fundal compliance with an increase in antral stretch and enhanced cholecystokinin activity leading to increased satiation.This anorexia leads to weight loss in aging persons and is one of the component causes of the aging related sarcopenia. This physiological anorexia also increases the risk of more severe anorexia when an older person has an increase in inflammatory cytokines such as occurs when they have an illness. This results in an increase in the anorexia due to cachexia in older persons.

[1]  M. Muscaritoli,et al.  The Three Faces of Sarcopenia. , 2016, Journal of the American Medical Directors Association.

[2]  S. Devic,et al.  Warburg Effect - a Consequence or the Cause of Carcinogenesis? , 2016, Journal of Cancer.

[3]  F. Landi,et al.  Anorexia of Aging: Risk Factors, Consequences, and Potential Treatments , 2016, Nutrients.

[4]  L. Ferrucci,et al.  SARC‐F: a symptom score to predict persons with sarcopenia at risk for poor functional outcomes , 2015, Journal of cachexia, sarcopenia and muscle.

[5]  J. Morley.  Pharmacologic Options for the Treatment of Sarcopenia , 2016, Calcified Tissue International.

[6]  S. Anker,et al.  Cachexia: a nutritional syndrome? , 2015, Journal of cachexia, sarcopenia and muscle.

[7]  S. Anker,et al.  Ethical guidelines for publishing in the Journal of Cachexia, Sarcopenia and Muscle: update 2015 , 2015, Journal of cachexia, sarcopenia and muscle.

[8]  A. Amin,et al.  Reverse Epidemiology of Traditional Cardiovascular Risk Factors in the Geriatric Population. , 2015, Journal of the American Medical Directors Association.

[9]  J. Morley,et al.  Pathophysiology of anorexia in the cancer cachexia syndrome , 2015, Journal of cachexia, sarcopenia and muscle.

[10]  J. Morley.  Peptides and aging: Their role in anorexia and memory , 2015, Peptides.

[11]  L. Donini,et al.  Effects of a vitamin D and leucine-enriched whey protein nutritional supplement on measures of sarcopenia in older adults, the PROVIDE study: a randomized, double-blind, placebo-controlled trial. , 2015, Journal of the American Medical Directors Association.

[12]  S. Anker,et al.  Evidence for partial pharmaceutical reversal of the cancer anorexia–cachexia syndrome: the case of anamorelin , 2015, Journal of cachexia, sarcopenia and muscle.

[13]  A. Asakawa,et al.  One-year intranasal application of growth hormone releasing peptide-2 improves body weight and hypoglycemia in a severely emaciated anorexia nervosa patient , 2015, Journal of cachexia, sarcopenia and muscle.

[14]  S. Anker,et al.  Treatment of cachexia: An overview of recent developments. , 2015, International journal of cardiology.

[15]  S. Burden,et al.  Understanding and managing cancer-related weight loss and anorexia: insights from a systematic review of qualitative research , 2015, Journal of cachexia, sarcopenia and muscle.

[16]  R. Witkamp,et al.  Differences in food intake of tumour-bearing cachectic mice are associated with hypothalamic serotonin signalling , 2015, Journal of cachexia, sarcopenia and muscle.

[17]  S. Anker,et al.  Treatment of cachexia: an overview of recent developments. , 2014, Journal of the American Medical Directors Association.

[18]  Yuanfeng Xia,et al.  Anamorelin HCl (ONO-7643), a novel ghrelin receptor agonist, for the treatment of cancer anorexia-cachexia syndrome: preclinical profile , 2014, Journal of cachexia, sarcopenia and muscle.

[19]  S. Anker,et al.  Are we closer to having drugs to treat muscle wasting disease? , 2014, Journal of cachexia, sarcopenia and muscle.

[20]  E. Hui,et al.  Obesity can benefit survival-a 9-year prospective study in 1614 Chinese nursing home residents. , 2014, Journal of the American Medical Directors Association.

[21]  P. Barberger‐Gateau,et al.  Efficiency at the resident's level of the NABUCCOD nutrition and oral health care training program in nursing homes. , 2014, Journal of the American Medical Directors Association.

[22]  C. Bales,et al.  Obesity and physical frailty in older adults: a scoping review of lifestyle intervention trials. , 2014, Journal of the American Medical Directors Association.

[23]  S. Anker,et al.  From sarcopenia to frailty: a road less traveled , 2014, Journal of cachexia, sarcopenia and muscle.

[24]  R. Witkamp,et al.  Hypothalamic food intake regulation in a cancer-cachectic mouse model , 2013, Journal of cachexia, sarcopenia and muscle.

[25]  M. Cesari,et al.  Proinflammatory cytokines, aging, and age-related diseases. , 2013, Journal of the American Medical Directors Association.

[26]  I. Chapman,et al.  Body weight, anorexia, and undernutrition in older people. , 2013, Journal of the American Medical Directors Association.

[27]  M. Cesari,et al.  Evidence-based recommendations for optimal dietary protein intake in older people: a position paper from the PROT-AGE Study Group. , 2013, Journal of the American Medical Directors Association.

[28]  J. Morley.  Pathophysiology of the anorexia of aging , 2013, Current opinion in clinical nutrition and metabolic care.

[29]  R. Iniesta,et al.  Effectiveness of nutritional supplementation on muscle mass in treatment of sarcopenia in old age: a systematic review. , 2013, Journal of the American Medical Directors Association.

[30]  G. Onder,et al.  Association of anorexia with sarcopenia in a community-dwelling elderly population: results from the ilSIRENTE study , 2013, European Journal of Nutrition.

[31]  A. Sainsbury,et al.  Anorexia/cachexia of chronic diseases: a role for the TGF-β family cytokine MIC-1/GDF15 , 2012, Journal of cachexia, sarcopenia and muscle.

[32]  J. Woo,et al.  Comparison of Frailty Indicators Based on Clinical Phenotype and the Multiple Deficit Approach in Predicting Mortality and Physical Limitation , 2012, Journal of the American Geriatrics Society.

[33]  J. Morley,et al.  A simple frailty questionnaire (FRAIL) predicts outcomes in middle aged African Americans , 2012, The journal of nutrition, health & aging.

[34]  J. Morley.  Anorexia of aging: A true geriatric syndrome , 2012, The journal of nutrition, health & aging.

[35]  S. Anker,et al.  The obesity paradox in chronic disease: facts and numbers , 2012, Journal of cachexia, sarcopenia and muscle.

[36]  Stephan von Haehling,et al.  An overview of sarcopenia: facts and numbers on prevalence and clinical impact , 2010, Journal of cachexia, sarcopenia and muscle.

[37]  L. Ferrucci,et al.  Nutritional recommendations for the management of sarcopenia. , 2010, Journal of the American Medical Directors Association.

[38]  J. Morley,et al.  Developing novel therapeutic approaches to frailty. , 2009, Current pharmaceutical design.

[39]  P. Ponikowski,et al.  Cachexia: a new definition. , 2008, Clinical nutrition.

[40]  J. Morley,et al.  Cachexia and neuropeptide Y. , 2008, Nutrition.

[41]  J. E. Morley,et al.  Sarcopenia: Diagnosis and treatment , 2008, The journal of nutrition, health & aging.

[42]  J. Morley,et al.  Cachexia: new advances in the management of wasting diseases. , 2008, Journal of the American Medical Directors Association.

[43]  J. Morley,et al.  Anorexia of aging in long term care: is dronabinol an effective appetite stimulant?--a pilot study. , 2007, The journal of nutrition, health & aging.

[44]  W. Banks,et al.  Orexin-A-induced feeding is dependent on nitric oxide , 2003, Peptides.

[45]  J. Wishart,et al.  Energy intake and appetite are related to antral area in healthy young and older subjects. , 2004, The American journal of clinical nutrition.

[46]  S. M. Robinson,et al.  Triglycerides induce leptin resistance at the blood-brain barrier. , 2004, Diabetes.

[47]  W. Banks,et al.  Ghrelin-induced feeding is dependent on nitric oxide , 2003, Peptides.

[48]  J. Morley.  Anorexia and weight loss in older persons. , 2003, The journals of gerontology. Series A, Biological sciences and medical sciences.

[49]  J. Wishart,et al.  The effects of miglitol on glucagon‐like peptide‐1 secretion and appetite sensations in obese type 2 diabetics , 2002, Diabetes, obesity & metabolism.

[50]  J. Morley,et al.  Treating malnutrition with megestrol acetate: literature review and review of our experience. , 2002, The journal of nutrition, health & aging.

[51]  J. Morley,et al.  Effect of liquid dietary supplements on energy intake in the elderly. , 2002, The American journal of clinical nutrition.

[52]  Bernhard Schink,et al.  Energetics and kinetics of lactate fermentation to acetate and propionate via methylmalonyl-CoA or acrylyl-CoA. , 2002, FEMS microbiology letters.

[53]  J. Wishart,et al.  Effect of exogenous cholecystokinin (CCK)-8 on food intake and plasma CCK, leptin, and insulin concentrations in older and young adults: evidence for increased CCK activity as a cause of the anorexia of aging. , 2001, The Journal of clinical endocrinology and metabolism.

[54]  J. Morley,et al.  Leptin and neuropeptide Y (NPY) modulate nitric oxide synthase: further evidence for a role of nitric oxide in feeding , 1999, Peptides.

[55]  B. Vellas,et al.  Anorexia of aging, leptin, and the Mini Nutritional Assessment. , 1999, Nestle Nutrition workshop series. Clinical & performance programme.

[56]  K. Hveem,et al.  Relation between postprandial satiation and antral area in normal subjects. , 1997, The American journal of clinical nutrition.

[57]  H. Perry,et al.  Testosterone replacement in older hypogonadal men: a 12-month randomized controlled trial. , 1997, The Journal of clinical endocrinology and metabolism.

[58]  M. Horowitz,et al.  Evidence for the anorexia of aging: gastrointestinal transit and hunger in healthy elderly vs. young adults. , 1997, The American journal of physiology.

[59]  J. Morley,et al.  Evidence for a physiological role for CCK in the regulation of food intake in mice. , 1989, The American journal of physiology.

[60]  J. Morley,et al.  Bombesin inhibits stress-induced eating , 1981, Pharmacology Biochemistry and Behavior.